Abstract | The ability of cells to adhere to each other and to their surrounding extracellular matrices is essential for a multicellular existence. Adhesion provides physical support for cells, regulates cell positioning and enables microenvironmental sensing. The integrins and the syndecans are two adhesion receptor families that mediate adhesion, but their relative and functional contributions to cell-extracellular matrix interactions remain obscure. Recent advances have highlighted connections between the signalling networks that are controlled by these families of receptors. Here we survey the evidence that synergistic signalling is involved in controlling adhesive function and the regulation of cell behaviour in response to the external environment. 
Cells in tissues are structurally and functionally integrated with their surrounding extracellular matrices (ECMs) in highly organized processes that involve thousands of dynamic connections. The intracellular domains of adhesion receptors tether the contractile cytoskeleton to the plasma membrane and compartmentalize cytoplasmic signalling events. On the extracellular face, the same receptors direct and organize the deposition of the ECM itself. The membrane-proximal functions of adhesion receptors trigger distal processes within cells, including the alteration of the direction of cell movement and the regulation of cell fate, and determine long-range effects outside cells, such as the construction of ECM networks and the consequent shaping of higher-order tissue structure. Elucidating the molecular events that mediate the functional integration of multicellular tissues with spatially orientated ECMs and that control adhesion-regulated signalling are therefore of central importance if we are to understand the tissue-organizing principles of metazoan life.
Aberrations in ECM organization and cell-ECM interactions contribute widely to disease, demonstrating the essential role of the ECM. Many human diseases are caused by defects in cell-ECM coordination, are exacerbated by aberrant use of normal cell-adhesive processes or are potentially correctable by altering tissue structure or cell movement. For example, progressive extracellular remodelling in chronic atherosclerotic, fibrotic and neurodegenerative diseases ultimately leads to a loss of tissue integrity; altered adhesion is a defining characteristic of tumour malignancy; and the pathogenesis of inflammatory and thrombotic diseases relies on aberrant cell aggregation and/or migration. Notably, the incidence of many of these conditions is growing in parallel with increasing longevity in the population. The development of strategies to correct adhesive dysfunction therefore has enormous promise as a route to improving the treatment of many clinical conditions and thereby enhancing quality of life.
The cell-surface receptors that mediate cell-ECM adhesion are primarily members of two gene families -the integrins and the syndecans. Intriguingly, nearly all ECM molecules contain binding sites for both types of receptor and, as reviewed below, there is substantial evidence that a full cell-adhesion response requires engagement of both types of receptor. Integrins and syndecans are required for generating a physical link to the cytoskeleton, for force transduction, for spatial control of the assembly of the adhesion signalling complex (via adhesion contacts; BOX 1) , and for the regulation of cytoskeletal dynamics. Although mechanisms of direct receptor crosstalk have not yet been identified, in vitro analyses have demonstrated clear synergy between signalling cascades downstream of the two families (synergistic signalling).
This review draws together information from a series of recent studies that have shed light both on the molecular signals that arise from synergistic engagement of integrins and syndecans and on the in vivo consequences of cooperation between receptors.
Integrins and syndecans
The integrins are a family of transmembrane glycoproteins (FIG. 1) that form non-covalent heterodimers. In mammals, 18 α-and 8 β-integrin genes encode polypeptides that combine to form 24 αβ receptors 1 . The extracellular domains of integrins interact with various ligands, including Extracellular matrix (ECM) . A three-dimensional network of glycoproteins and proteoglycans that has a structural role in defining tissue architecture and that provides environmental cues to modulate cell signalling and behaviour. 
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PDZ domain
A protein-protein association domain that is present in the proteins post-synaptic density-95, disc large tumour suppressor and zonula occuldens-1.
ECM glycoproteins and cell-surface proteins 2 , and their cytoplasmic domains interact with components of the actin cytoskeleton. These bidirectional linkages exert spatial control on signalling and thereby control cellular differentiation and fate. Genetic analyses of mutant integrins have demonstrated that integrins have roles in tissue structure and cell migration 3, 4 . Integrins also participate in adhesive events during many pathophysiological processes, including haemostasis and thrombosis, inflammation, wound healing and neoplasia.
The syndecans are a family of membrane-intercalated proteoglycans, each comprising a protein core with covalently attached heparan sulphate or chondroitin sulphate glycosaminoglycan sugar chains that are substituted at 3-5 positions at the N terminus of the extracellular domain 5 (FIG. 1) . There are four members of the syndecan family in mammals, of which three (syndecan-1, -2 and -3) have a restricted tissue distribution -the fourth (syndecan-4) is expressed ubiquitously. The syndecans act as receptors for ECM proteins and for growth factors, engaging ligands through the large flexible glycosaminoglycan chains that make them ideal receptors for ligands that are dilute or distant from the membrane. The necessity of the glycosaminoglycan chains is demonstrated by the fact that cellular responses to ligands such as fibronectin, fibroblast growth factor-2 (FGF2) and vascular endothelial growth factor (vEGF) are inhibited if the interactions of the sugar chains are compromised by the addition of soluble competitors or disruption of the glycosaminoglycan biosynthetic machinery 6, 7 . distinct from the role of the glycosaminoglycan chains of syndecans, there are reports that the protein cores of the extracellular domains of syndecans themselves act as integrin ligands [8] [9] [10] , and these might represent an alternative mechanism of receptor cooperation, although this has not yet been investigated in depth. The cytoplasmic domains of syndecans comprise a pair of conserved regions that is present in all isoforms and a variable region that is unique to each syndecan (FIG. 1) . The variable region of syndecan-4 encompasses a binding site for protein kinase Cα (PKCα), and the presence of this motif, combined with the ubiquitous expression of syndecan-4, has made syndecan-4 a primary focus of investigation into syndecan signalling.
For two decades it has been appreciated that focal adhesion (FA) formation (BOX 1) during cell spreading on fibronectin depends on the engagement of an integrin and a cell-surface proteoglycan (specifically, α 5 β 1 integrin and syndecan-4 (REFs 11,12)) (FIG. 2) . rNA interference (rNAi) knockdown and mutagenesis studies have subsequently revealed the cooperation of α v β 3 integrin and α v β 5 integrin with syndecan-1 during adhesion to vitronectin 8, 9 , and cooperation of α 2 β 1 integrin and α 6 β 4 integrin with syndecans during adhesion to laminin 13, 14 . This range of integrin-syndecan receptor pairs suggests widespread cooperation between the families and raises the possibility that, depending on cellular context, different receptor combinations can differentially modulate cellular responses to different extracellular stimuli. A key challenge for the field is to define the molecular basis for the functional connection between integrin and syndecan signalling.
The contribution of integrins to cell adhesion has largely been demonstrated through the use of inhibitory antibodies and overexpression studies. despite an extraordinary effort by the field, the molecular connection between adhesion receptor occupancy and cytoplasmic signalling remains poorly defined, and a direct link between integrin and the cytoskeleton has only recently been established through resolution of the atomic structure of the cytoplasmic tail of β 3 integrin complexed with the head domain of the cytoskeletal protein talin 15 . Integrin conformation is influenced by the associations of both the extracellular and the cytoplasmic domains, and cytoplasmic signals that lead to integrin activation from inside the cell (inside-out signalling) seem to converge on talin, as demonstrated by rNAi knockdown 16 and fluorescence resonance energy transfer (FRET) analyses 17 . Conversely, the initiation of cytoplasmic signals, downstream of integrin, in response to an ECM signal (outside-in signalling) is reported to be talin-independent and relies on the activation of Tyr kinases by an unresolved pathway 18 . Cytoplasmic signalling downstream of syndecan-4 is much easier to explain, owing to the presence of well characterized PKCα-and PDZ-domain-binding sites in the cytoplasmic domain of syndecan-4 (REFs 19, 20) . Further putative interactions of syndecan's cytoplasmic domains with Tyr kinase complexes 21 and membrane-binding proteins 22 have been described, but the small size of the cytoplasmic domains
Box 1 | Variability among different forms of adhesion contacts
In most cells in vitro, adhesion signalling complexes (also known as adhesion contacts) are distributed focally rather than diffusely and are manifested as asymmetric patches, flecks and stripes. These contact points are found all over the ventral surface of cells and are usually associated with the contractile polymers of the cytoskeleton. Detailed morphological and functional analyses in fibroblasts have defined three major forms of adhesion contact: focal complexes (FCs), focal adhesions (FAs) and fibrillar adhesions (FBs) 120 (see figure) . These forms of contact reflect different stages of interactions of cells with the extracellular matrix (ECM), and each is formed and disrupted in a cyclical manner as cells translocate. Initially, FCs form immediately behind the leading edge of a cell, where they anchor the short filopodial struts and lamellipodial meshes of actomyosin that mediate membrane protrusion. When protrusion ceases or the lamellipodium retracts, FCs transform into larger FAs, which provide a more robust anchorage via transcellular, contractile actomyosincontaining stress fibres. In turn, FAs evolve into centrally located FBs, which are the major sites of fibronectin matrix deposition 121 . In keeping with their variable size, shape and location, there is some evidence for heterogeneity in the composition of adhesion contacts: FCs lack zyxin 122 , whereas FBs lack phosphotyrosine and α V integrins 123 but contain tensin. Adhesion-contact-like structures have been observed in vivo in smooth muscle cell plaques and myotendinous junctions 124 and, recently, in embryonic threedimensional ECM 125 , thereby validating the use of cell cultures for analysis. However, as cells are normally surrounded by an ECM in vivo rather than being immobilized on a two-dimensional surface, it is likely that the relative proportions of different adhesion complexes will vary between cell types. Scale bar in the figure represents 10 µm. 25 . As it has become increasingly apparent that regulation of these pathways depends on simultaneous engagement of multiple adhesion receptors, the identification of the key nodal points at which receptor signalling is coordinated has become a priority, and the major adhesion-regulated pathways that are downstream of ECM engagement -protein kinase signalling and rho-family GTPase signalling -are considered below.
Signalling through protein kinases PKC is directly regulated by syndecan-4. A proteinkinase binding motif was identified early during the characterization of syndecan-4 (REF. 26 ). unlike other members of the syndecan family, syndecan-4 specifically recruits PKCα to FAs and activates it through a unique interaction between the variable region of the cytoplasmic domain of syndecan-4, the kinase domain of PKCα and the inositol lipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P 2 ) 19 (FIG. 3) . Formation of this ternary complex is itself regulated by the phosphorylation of the cytoplasmic domain of syndecan-4 at a different site by PKCδ, which affects both activation of PKCα and oligomerization of the cytoplasmic tails 27 . In support of a positive role for PKC signalling in syndecan function, expression of dominant-negative PKCα blocks syndecan-4-induced migration 28 . Intriguingly, FrET analysis reveals a close association between active PKCα and β 1 integrin that promotes the migration of cells on ECM substrates, such as fibronectin, collagen and laminin 29 . These observations suggest the possibility of a connection between syndecan-4 and integrin, via PKCα, that primes the integrin for migration; indeed, recent evidence suggests that the activation of α IIb β 3 integrin depends on both talin and active PKCα
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. Increasingly, evidence suggests a role for PKC signalling in regulating the surface expression of integrins. PKC-induced migration of breast carcinoma cells is inhibited by blocking the endocytosis of β 1 integrin using a dominant-negative mutant of dynamin 29 , and a direct interaction between syndecan-4 and dynamin-2 has been identified by yeast two-hybrid and immunoprecipitation experiments 22 . Although syndecan-1 and β 5 integrin have been found to co-precipitate 9 , it appears that syndecan-4 and β 1 integrin are not directly associated, because the expression of dominant-negative 126, 127 . In mammals, 18 α-and 8 β-integrin genes encode polypeptides that combine to form 24 αβ receptors, out of 144 possible combinations. The extracellular domain structure of each subunit is conserved between isoforms, with the exception of a subset of α-subunits (α1, α2, α10, α11, αX, αM, αL, αD and αE) that include an inserted 'A-domain' in their ligand-binding pocket 2 . The cytoplasmic interactions of integrins are mostly mediated by the cytoplasmic tail of the β-subunit and, indeed, integrins can be activated by direct association of the cytoplasmic tail of the β-subunit with the cytoskeletal protein talin 15 (the talin-binding domain is shown). Only the integrin subunits that form the heterodimers that are discussed in this review are shown. b | Syndecans exist as homodimers and bind to the matrix through glycosaminoglycan chains that are substituted at 3-5 positions on the extracellular domain 5 . The short cytoplasmic domains can be subdivided into two conserved regions -C1 and C2 -that bind Src/Fyn Tyr kinase complexes and PDZ-domain-containing proteins, respectively, and a central variable region. The variable region confers specific properties on each syndecan and, most notably, the variable region of syndecan-4 is a binding site for protein kinase Cα.
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Endothelial cell
A specialized epithelial cell that forms a layer that lines the lumen of blood vessels, lymph vessels and the heart. dynamin has no effect on the endocytosis of syndecan-4 in endothelial cells 31 . Instead, the surface expression of syndecan isoforms has been reported to depend on an association with the second PdZ domain of the scaffolding protein syntenin 32 (FIG. 3) . Mutating either syntenin or the C terminus of syndecan prevents the recycling of syndecans, which causes the accumulation of syndecan and integrin in endosomes and compromises cell spreading. Together, these experiments suggest that communication between integrin and syndecan is responsible for the delicate balance in integrin cycling that is necessary for rapid cell migration. determining the extent to which integrin and syndecan molecules interact and regulate one another is now a priority for the field, and developing the ability to visualize and track syndecan-4 reliably will accelerate our understanding of receptor cooperation.
Integrins mediate attachment to various extracellular ligands 2 , and there are indications that the signals that are activated as a consequence of integrin and syndecan engagement vary depending on the integrin that is involved. syndecan-4-dependent regulation of PKCα is essential for FA formation and for migration in cells that adhere to fibronectin through α 5 β 1 integrin (but not through α 4 β 1 integrin, which occurs independently of syndecan) 28 . similarly, the form of myristoylated Alarich C-kinase substrate (MArCKs) that is phosphorylated by PKCα redistributes from the membrane to the cytosol during the period of adhesion-induced PKC activity and is essential for α 5 β 1 integrin-mediated spreading of myoblasts on fibronectin, although it is unnecessary for α 7 β 1 integrin-mediated spreading on laminin 33 . The requirement for PKCα activity for FA formation on fibronectin (FIG. 2f) is a reflection of the synergy between α 5 β 1 integrin and syndecan-4 and is consistent with the unique ability of syndecan-4 to regulate PKCα. Yet, although PKCα appears to be an essential mediator of signals downstream of syndecan-4, it might not be necessary for all integrin-mediated adhesion.
Tyr kinases as effectors of adhesion signalling. Integrins lack intrinsic enzymatic activity and, therefore, regulate signalling cascades through the recruitment and activation of non-receptor kinases. similarly, ECM engagement of syndecan-4, which is itself phosphorylated by src family kinases 34 , has been linked to the activation of two key adhesion-dependent Tyr kinases, focal adhesion kinase (FAK) and src. A protein complex that includes src and its close relative, Fyn, reportedly binds to the membrane-proximal region of the cytoplasmic tail of syndecan-3 and becomes activated in response to the clustering of syndecan-3 (REF. 21 ). Although connections between syndecan-4 and src are limited to reports of colocalization, the fact that the src-binding motif is conserved in all syndecans makes it likely that regulation of src is relevant to the whole family (FIG. 3) . Interestingly, it has been reported that both src and Fyn are activated by direct association with the cytoplasmic tail of β 3 integrin, but not with the cytoplasmic tails of β 1 integrin or β 2 integrin 18 , and these data might provide another example of cooperation between syndecans and a specific subset of integrins.
Evidence that syndecan-4 contributes to the regulation of FAK is more robust. FAK is activated by autophosphorylation of Tyr397 as cells spread on whole fibronectin, but not on a fibronectin fragment that lacks the syndecan-binding domain 35 . levels of phosphorylated FAK are reduced by the disruption of syndecan-4 and are not restored by the activation of PKC with phorbol acetate 36 . like PKCα, FAK has been linked to dynamin-mediated endocytosis. Microtubule-directed disassembly of FAs is blocked by the inhibition of FAK or dynamin activity, and recruitment of dynamin to FAs depends on the association between dynamin and activated FAK 37 . Consequently, we might envisage a role for syndecan-4 in regulating dynamin-mediated endocytosis by a non-linear pathway that involves both PKCα and FAK, and a similar level of crosstalk between ser/Thr and Tyr kinases would go some way to explaining the contributions of syndecans to adhesion-contact formation.
Signalling through Rho-family GTPases Rac1 activation is dependent on receptor synergy. The rho family of GTPases is central to cytoskeletal organization; members of this family cycle between active (GTP-bound) and inactive (GdP-bound) forms owing to their intrinsic GTPase activity 23, 38 . The best-characterized rho GTPases are rac1, which drives membrane protrusion and the formation of nascent focal complexes, and rhoA, which drives FA maturation and actin-filament bundling. Adhesion to fibronectin initiates the transient activation of rac1 and downstream effectors 39 , a process that is blocked by mutation of the cytoplasmic tail of β 1 integrin 40 . recent investigation into rac1 regulation revealed the extent of cooperation between α 5 β 1 integrin and syndecan-4 (FIG. 4) . Engagement of both receptors was necessary for the activation of rac1 in response to fibronectin, and localized activation of rac1 at the leading edge of a migrating cell was the direct consequence of syndecan-4 signalling 41 . rac1 activity is also necessary for the endocytosis of both syndecan-4 and FGF2 (REF. 31 ), establishing a feedback loop between syndecan-4 and rac1 as well as a link to growth-factor signalling that might affect adhesion-dependent rac1 signalling. Inhibition of the epidermal growth factor (EGF) receptor disrupts adhesion-dependent rac1 regulation 42 , suggesting that the convergence of signals downstream of integrins, syndecans and growth-factor receptors complements the need for heparan-sulphate chains in pathological angiogenic responses to vEGF and FGF2 (REF. 6 ).
Clustering of the cytoplasmic domains of syndecan-4, but not of syndecan-1, accelerates cell migration in scratch-wound assays on fibronectin and is abrogated by deletion of the C-terminal PdZ-ligand motif 43 . The migration of fibroblasts on fibronectin fragments is compromised in the absence of syndecan ligand 44 , and knockdown of syndecan-1 similarly compromises . PtdIns(4,5)P 2 -binding can be prevented by the phosphorylation of syndecan-4 by PKCδ, which introduces a negative charge into the otherwise basic region of the cytoplasmic tail of syndecan-4 (REF. 19 ). Independent studies have reported that PKCα activity, in cooperation with talin binding, is necessary for integrin activation 30 , whereas other reports describe the role of PKCα in clathrin-dependent endocytosis of α 5 β 1 integrin 29 . Activation of the Tyr kinase focal adhesion kinase (FAK) as a cell spreads on fibronectin depends on the engagement of both α 5 β 1 integrin and syndecan-4. Src family kinases, which themselves contribute to the activation of FAK, are activated in response to integrin engagement, bind indirectly to the cytoplasmic domain of syndecans 21 and are responsible for Tyr phosphorylation of the syndecan 34 . FAK regulates focal-adhesion disassembly by associating with dynamin, which itself binds to the cytoplasmic domain of syndecan-4 (REF. 22 ) and is necessary for integrin endocytosis. Endocytosis and recycling of syndecan-4 is not directly coupled to integrin cycling, but instead depends on an ARF6-dependent association of the C terminus of the cytoplasmic domain of syndecan and one of the paired PDZ domains of the small scaffolding protein syntenin PKCα migration on vitronectin 8 . Each of these findings is consistent with the hypothesis that syndecans regulate rac1 activity, yet surprisingly disruption of syndecan-4 expression actually increases steady-state rac1 activity 41, 45 . rather than acting as a positive rac1 regulator, expression of unengaged syndecan-4 suppresses rac1 activity and only drives the activation of rac1, in a PKCα-dependent manner, at points of ECM engagement 41 (FIG. 4) . Investigations into the role of rac1 in cell migration have shown that its activity influences the persistence, rather than the speed, of migration 46, 47 . Over-activation of rac1 limits the persistence of migration by increasing random protrusion. Thus, syndecan-4 limits rac1 activity in the absence of ligand engagement and results in persistent migration by restricting rac1 activity to the leading edge 41 . This finding could explain the crucial contribution of syndecan-4 to wound healing (see below).
Varied effects of adhesion receptors on Rac1 and RhoA. ECM engagement of syndecan-4 also effects rhoA signalling. ECM engagement by syndecan-4 causes, although is not essential for, a wave of rhoA regulation 41, 48 , and treatment of cells with the rho inhibitor C3 exotoxin blocks FA formation in response to syndecan-4 (REF. 49 ). syndecan-4-dependent regulation of both rac1 and rhoA requires the activation of PKCα 41, 48 , whereas independent activation of rhoA by lysophosphatidic acid bypasses the requirement for syndecan-4 ligand or active PKC in FA formation 49 . These experiments demonstrate that GTPase regulation lies downstream of PKCα activity and provide a crucial link from the cytoplasmic domain of an adhesion receptor to GTPase signalling. As with PKC signalling, the relative contributions of integrin and syndecan-4 to GTPase signalling depend on the integrin involved. Overexpression of β 1 integrin, but not of β 3 integrin, causes rhoA activation, whereas neither integrin has a strong effect on loading GTP onto rac1 (REF. 50 ). rather than activating rac1, antibody-clustering of β 1 integrin causes redistribution of rac1 to the membrane by reorganization of lipid microdomains: a response that could be enhanced by serum stimulation or expression of active rac1 (REF. 51 ). These alternative mechanisms of rac1 regulation suggest that syndecan-4 and integrin might cooperate by separately driving GTP loading and membrane recruitment, respectively, with both events being necessary for the activation of downstream effectors. such a model would highlight the importance of synergy between receptors and point to rac1 as a convergence point for signals from integrins and syndecan-4.
The range of signalling pathways regulated by various integrin-syndecan pairs points towards two key conclusions: first, as outlined above, the circumstances of syndecan-4 engagement by the ECM and the complement of other receptors involved result in varied cellular responses to the ECM; second, the localized regulation of signalling molecules, both spatially and temporally, by ECM receptors is more important than the holistic activation of a molecule throughout a cell. The ability to regulate signals differentially at the leading and trailing edges is particularly important for cell migration and determines both the polarity and velocity of migration. As we move on to consider the effects of integrinsyndecan function in vivo, it becomes increasingly clear that the regulation of cell migration is central to many integrin-syndecan-mediated biological processes. Further links between receptor synergy and Rac1 might be mediated by focal adhesion kinase (FAK) and paxillin. ECM engagement of integrins (for example, α 5 β 1 integrin) causes redistribution of lipids, including cholesterol and the ganglioside GM-1, into detergentinsoluble membrane microdomains and is necessary for the redistribution of GTP-Rac1 to the membrane, where it associates with downstream effectors, such as p21-activated kinase (PAK; left) 51 . The localized activation of Rac1 and RhoA initiates signalling cascades that regulate membrane protrusion (left) and reorganization of the actin cytoskeleton (right). Thick arrows represent translocation. PtdIns(4,5)P 2 , phosphatidylinositol-4,5-bisphosphate.
Directional migration
Cell migration directly towards a chemical gradient or along a fibrillar structure. It is distinct from random migration, in which direction is determined by chance and changes frequently.
Angiogenesis
The growth or sprouting of new blood vessels from a preexisting vessel network.
Granulation tissue
Fibrous connective tissue that develops in wounds. Granulation tissue comprises fibroblasts, endothelial cells, myofibroblasts, inflammatory cells and provisional extracellular matrix.
Keratinocyte
An epidermal cell that expresses keratins.
Vasculogenesis
De novo formation of blood vessels, primarily during development, from the differentiation of endothelial cell precursors (angioblasts).
Integrin-syndecan synergy in vivo
Having discussed the molecular basis of integrin and syndecan function, it is apparent that cooperative signalling between the two receptors is fundamental for cellular responses to the ECM. In the following sections, the potential role of synergy between syndecans and integrins in vivo is reviewed. Classical approaches to determining biological function (such as genetic analysis of development in whole organisms or analysis of inappropriate receptor expression during the pathogenesis of disease ) have not yet been used to test the significance of integrin-syndecan synergy directly. However, there are many similarities between the physiological defects caused by interference with integrin or syndecan expression and function in vivo that could potentially be explained by molecular synergy between the molecules. A common feature of these processes that is consistent with the effect of such receptor synergy determined at the cellular level is the precisely coordinated regulation of directional migration.
Wound healing in adults. The process of wound healing is complex and involves precise regulation of clotting and coagulation, cell infiltration, angiogenesis and reepithelialization. It is well established that the expression of many integrins is modulated during epithelial wound healing [52] [53] [54] , with receptor levels often regulated by growth factors or exposure to the ECM 55, 56 . Transgenic mice that are deficient in the expression of β 3 integrin exhibit accelerated and dysregulated re-epithelialization 55 , suggesting that integrin function is pivotal to the process of wound healing. In uninjured mouse and neonatal human skin, syndecan-4 is found only on epidermal cells; however, following injury, expression is upregulated throughout the dermis and on endothelial cells and fibroblasts in granulation tissue 57 . The major defect detected in syndecan-4-knockout mice is impaired wound healing in adults. As fibroblasts cultured from syndecan-4 -/-mice displayed reduced migration in a scratch-wound assay in vitro 58 , it seems most likely that the reduced level of wound healing in syndecan-4 -/-mice is, at least in part, a function of suppressed migration (although, as described below, syndecan-4 signalling might also regulate angiogenic processes in the wound bed). Moreover, a recent study has found that rac1, which is regulated by the simultaneous engagement of α 5 β 1 integrin and syndecan-4 (REF. 41) (FIG. 4) , is required for efficient keratinocyte migration and wound healing in vivo 59 , suggesting a possible means by which integrin-syndecan synergy could regulate wound healing.
syndecan-1 has a well established role in the woundhealing response. syndecan-1 expression is restricted to the epithelium of normal mouse tissue 60 and is upregulated in dermal endothelial cells and granulation tissue fibroblasts during tissue repair 61 . This switch in expression mirrors the change in syndecan-1 expression that occurs during embryonic epithelial cell morphogenesis, when expression of syndecan-1 becomes reduced in the epithelium and elevated in associated mesenchymal cells 62 . After protease-or growth-factor-mediated shedding, the syndecan-1 ectodomain accumulates in wound fluid and granulation tissue 5, 63 . like syndecan-4-knockout mice, syndecan-1-deficient mice are healthy and fertile; however, they display a defect in both corneal and skin re-epithelialization. This defect is a result of impaired keratinocyte proliferation, migration and integrin localization 64 . Interestingly, targeted ablation of the syndecan-1 gene in mice results in elevated transcription of the α 3 integrin and α 9 integrin subunits 64 , suggesting another mode by which syndecan and integrin function can be linked. Transgenic mice that overexpress syndecan-1 also exhibit impaired wound healing; this is a consequence of increased levels of shed syndecan-1 ectodomain at the wound site, where it acts as a dominant-negative regulator of syndecan-1 function 65 . so, syndecan-1 and syndecan-4 are involved in wound healing. However, whereas syndecan-1 seems to be primarily involved in keratinocyte function and re-epithelialization, syndecan-4 seems to be primarily associated with fibroblast migration, wound contraction and angiogenesis 58, 64 .
Developmental and pathological angiogenesis. Angiogenesis has a central role in embryonic development, wound healing and tumour progression. In vivo studies have demonstrated that many integrins are involved in the precise regulation of both developmental and pathological angiogenesis. Of these, α 5 β 1 integrin, α v β 3 integrin (FIG. 5a ; supplementary information s1 (animation)) and α v β 5 integrin, the integrins with which syndecans have primarily been shown to synergize, can be considered to be principal regulators of angiogenesis 66, 67 . Expression of the α 5 β 1 integrin heterodimer is elevated in endothelial cells during angiogenesis, and mice deficient in α 5 integrin exhibit embryonic-lethal developmental defects that include substantially disrupted vasculogenesis 68 . developmental angiogenesis is unlikely to rely on the synergistic signalling between α 5 β 1 integrin and syndecan-4 because there are no significant angiogenic defects in syndecan-4-null mouse embryos 58 (FIG. 5b) . However, an angiogenic role for syndecans in adult animals is supported by the fact that syndecan-4-deficient mice exhibit reduced angiogenesis in the granulation tissue of the wound bed 58 . Therefore, it is possible that syndecan-4, through cooperation with α 5 β 1 integrin, might modulate elements of postnatal and/or pathological angiogenesis. A separate study of syndecan-4-knockout mice revealed that they have reduced numbers of fetal vessels in the placental labyrinth, although the authors speculated that this might be a result of an impaired anti-coagulation mechanism as opposed to a direct effect on neovascularization 69 . A role for syndecans in developmental vasculogenesis has been described only in Danio rerio (zebrafish). syndecan-2 is expressed on cells that are proximal to the major trunk vessels, and genetic ablation of syndecan-2 leads to decreased angiogenic sprouting during vascular development 70 (FIG. 5b) . reconstitution of syndecan-2 expression rescues the angiogenic defect and depends on the integrity of the cytoplasmic domain of the syndecan and therefore, presumably, on downstream signalling. Moreover, syndecan-2-mediated angiogenesis has not yet been determined whether this involves the direct, heparan-sulphate-dependent, interaction of syndecan-2 with vEGF to facilitate association of the growth factor with its receptor 70 . A role for integrins in zebrafish angiogenesis has not been firmly established, but because so many integrins are associated with both physiological and pathophysiological angiogenesis in other organisms, it seems unlikely that D. rerio will be an exception.
Over the past decade it has become apparent that the function of α v β 3 integrin is central to the regulation of pathological angiogenesis (FIG. 5a; supplementary information s1 (animation)). However, many recent studies in this exciting and rapidly developing field have highlighted the truly complex nature of this regulation, especially the regulatory and compensatory effects of numerous growth-factor receptors and other integrin heterodimers (particularly α v β 5 integrin) (comprehensively reviewed in REFs 66, 67) . α v β 3 integrin is expressed de novo in angiogenic vascular tissue 71 and its inhibition, like inhibition of α 5 β 1 integrin, induces caspase-dependent apoptosis of angiogenic vessels and reduces tumour growth [72] [73] [74] [75] (FIG. 5a ; supplementary information s1 (animation)). However, surprisingly, mice that are deficient in α v β 3 exhibit enhanced tumour angiogenesis as a result of elevated vEGF receptor-2 (vEGFr2) expression and signalling 76, 77 (FIG. 5a; supplementary information s1 (animation)). until recently, α v β 3 integrin and α v β 5 integrin were considered to form distinct functional pairs with the proangiogenic growth factors FGF and vEGF, respectively 67 . However, a recent study indicated that the ability of α v β 3 integrin to mediate bidirectional signalling regulates the capacity of a tumour to secrete vEGF. Tumours that expressed inactive α v β 3 integrin secreted reduced levels of vEGF and exhibited suppressed angiogenesis and tumour growth 78 . On endothelial cells, phosphorylation of the cytoplasmic domain of the β 3 integrin subunit is required to induce vEGF-stimulated, vEGFr2-phosphorylation-dependent, pathological angiogenesis 79 . Moreover, the cross-activation and mutual phosphorylation of α v β 3 integrin and vEGFr2 is src-dependent, is required for the formation of the α v β 3 integrin-vEGFr2 complex and is necessary for endothelial cell directional migration 80 (FIG. 5a ; supplementary information s1 (animation)).
Consequently, some of the key outstanding questions that now need to be addressed are: precisely what is the nature of the α v β 3 -vEGF-vEGFr axis? Are the biological effects that result from antagonism of α v β 3 integrin entirely independent of those that result from a deficiency of α v β 3 integrin expression? How does pathological angiogenesis differ from developmental vascularization? Intriguingly, in vitro studies in a limited number of cell types have demonstrated that syndecan-1 can regulate α v β 3 integrin activation, ligand-binding affinity Panel a shows a summary of the functional interplay between α V β 3 integrin, vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR2) in pathological angiogenesis. This interplay highlights how syndecan-1 could potentially have the capacity to regulate differentially the α V β 3 integrin and the VEGF-VEGFR signalling network (blue boxes and dotted arrow). Perturbing α V β 3 integrin function in vivo can have remarkably different effects on pathological angiogenesis, depending on the nature of the perturbation and the cell type that is expressing the integrin. Antagonism of α V β 3 integrin 72, 75 or expression of mutant β 3 subunits with compromised signalling capabilities [78] [79] [80] inhibits angiogenesis (seemingly through the modulation of different pathways), whereas mice that are deficient in β 3 integrin exhibit enhanced pathological angiogenesis 76, 77 . Further characterization of these phenomena has demonstrated a proangiogenic cross-activation of α V β 3 integrin and VEGF-VEGFR. In vitro studies suggest that syndecan-1, through integrin activation and growth-factor presentation, could possibly modulate this molecular network at various points (blue boxes) 6, 8, 83 . There are also fundamental differences between α V β 3 integrin-dependent regulation of pathological angiogenesis (a) and developmental neovascularization (b). In panel b, inhibition of β 3 integrin ligand binding can disrupt developmental vascularization 128 , whereas perturbation of β 3 integrin expression 76 or phosphorylation 79 has no effect. Syndecan-1-and syndecan-4-deficient mice, unlike syndecan-2-morpholino zebrafish, do not exhibit significant developmental angiogenic defects 58, 64, 70 .
Functional synergy
When at least two molecules and/or receptors transduce separate intracellular signals that regulate independent cellular processes, but these processes synergize to modulate the same cellular event in vivo. and signalling 8, 81 , as well as the activity of α v β 5 integrin 9 . Moreover, syndecans and other heparan sulphate proteoglycans are known to facilitate interactions between various growth factors and their receptors 5, 6, 82, 83 . Considering these data, it is possible to speculate that syndecan-1 could influence many of the α v β 3 integrin-and vEGFmediated functions that regulate pathological angiogenesis (FIG. 5; supplementary information s1 (animation) ). so, integrin-syndecan synergy might hold the key to answering some of these important questions.
A role for syndecan-1 in the regulation of angiogenesis in vivo is supported by the fact that syndecan-1-deficient mice have an increased predisposition to injury-induced angiogenesis of the ocular vasculature 84 . Furthermore, during inflammatory angiogenesis, syndecan-1 is upregulated following stimulation of ephrin receptor-b4 (Ephb4)-positive endothelial cells with the pro-angiogenic ligand of Ephb4, ephrin-b2 (REF. 85 ). Intriguingly, stimulation with ephrin-b2 also significantly increases the transcription of α 5 β 1 integrin, vEGF-C and hepatocyte growth factor in endothelial cells 85 .
The importance of integrins in tumour angiogenesis -especially of α 5 β 1 , α v β 3 and α v β 5 -is now well established 67 . However, little research has been done into the role of syndecans in the neovascularization of tumours, which is surprising given their synergistic relationship with these integrins. syndecan-1 expression on tumour and stromal tissue appears to be differentially regulated in various solid cancers 82 , elevated syndecan-1 is detected in the plasma of patients with myeloma, and the level of syndecan-1 detected in blood or bone marrow correlates with the density of microvessels and patient survival 86 . It is conceivable that the expression of syndecan-1 could have either a pro-or anti-angiogenic role; presumably this would depend on the cellular context, syndecan shedding and the extracellular environment (including the availability of growth factors, ECM and guidance cues, and the expression of their receptors) (FIG. 6) . The role of syndecan-1-mediated signalling in angiogenesis and α v integrin regulation is unknown, but it is possible that the spatially regulated ligation of integrins and syndecans could elicit intracellular signals that fine-tune angiogenic processes.
The signalling molecules that are associated with integrin-syndecan synergy at the molecular and cellular levels can also regulate angiogenesis, suggesting a possible role for synergistic signalling rather than simply functional synergy. Antisense-oligonucleotide-mediated inhibition of PKCα in vivo suppresses neovascularization in a model of cardiac ischaemia 87 , whereas inhibition of PKCα in vitro decreases angiogenic sprouting, endothelial migration, and vascular tube formation and permeability 87, 88 . Transgenic overexpression of FAK in the endothelia of mice promotes angiogenesis in the granulation tissue of wounds and in response to ischaemia 89 , whereas endothelium-specific FAK deficiency results in defective developmental angiogenesis 90 . Furthermore, in vivo delivery of FAK small interfering (si)rNA decreases microvessel density and tumour mass in a mouse model of ovarian cancer 91 . locally increased expression of FAK promotes retinal neovascularization in mice, whereas this phenomenon is reduced by the expression of a dominant-negative construct of FAK 92 . Also, inhibition of the cyclooxygenase-2 enzyme in vivo reduces α v β 3 -dependent activation of rac1, resulting in suppressed growth-factor-induced angiogenesis 93 . rac1 is required in vitro for endothelial branching morphogenesis, and its downstream effector, p21-activated kinase (PAK), mediates endothelial cell motility 94 . In addition, rac1 activation increases the expression of vEGF and thereby promotes angiogenesis 95 . Collectively, these reports suggest that the convergence of signalling events downstream of syndecan and integrin engagement could have a profound effect on angiogenesis, and they emphasize the potential importance of receptor synergy in the biology of higher eukaryotes.
Axonal guidance and neurite outgrowth. Axonal guidance is characterized by directional migration and responses to external cues (which include ECM molecules as well as growth, chemoattractive and repulsive factors). In vertebrates, syndecan-3 (also known as N-syndecan) is expressed in neurons that migrate along nerve bundles 96 , and neuronal migration is perturbed in syndecan-3-null mice, possibly as a consequence of disrupted src kinase activity 97 . Numerous β 1 integrin heterodimers and ECM molecules also modulate neuronal migration and function in mice 98, 99 . Any functional synergy between integrins and syndecans in neuronal development and axonal guidance appears to be evolutionarily conserved, because integrins and syndecans also have a role in neural patterning in invertebrates.
The slit-robo system is a key regulatory pathway in the mediation of chemorepulsion of developing axons at the midline. slit is a secreted ligand for robo transmembrane receptors and acts as a short-range chemorepellent to control the direction of axonal projections. In the developing Drosophila melanogaster embryo, the single syndecan gene (Sdc) is expressed in tissues that are adjacent to those that express slit, and the syndecan is co-expressed with robo in longitudinal axons 100 . Axonal expression of syndecan, although having no influence on the expression of slit or robo, is essential for neuronal responsiveness to slit. so, sdc mutants are phenotypically similar to robo mutants, producing neural defects in which axon bundles cross the midline. syndecan also interacts both genetically and physically with robo and slit 100 , thereby providing a means to regulate slit localization 101 (FIG. 6) . In Caenorhabditis elegans, the only syndecan orthologue (sdN-1) also regulates axonal guidance and neural outgrowth, at least in part, by modulating the slit-robo pathway 102 . A role for integrins in slit-mediated axonal guidance has also been described, whereby integrin-mediated adhesion of D. melanogaster neurons modulates axonal responsiveness to slit-mediated chemorepulsion 103 . Interestingly, the slit-robo pathway, which has been characterized primarily in the regulation of axonal guidance, has also been implicated in tumour angiogenesis and vascular guidance. slIT2 is expressed by many human tumours, and its receptor, rObO1, is expressed on the surface of vascular endothelial cells. slIT2 functions as a chemoattractant for rObO1-expressing endothelial cells and induces endothelial tube formation in vitro; in vivo tumour growth and angiogenesis can be inhibited by antibody-mediated blockade of rObO1 function 104 . Owing to the involvement of integrins and syndecans in the modulation of slit-robo function during axonal guidance, it is possible that regulation of the slit-robo system might provide another means by which integrin-syndecan synergy could control angiogenesis in vivo.
The various signalling molecules that are implicated in integrin-syndecan synergistic signalling also appear to have a role in neural patterning and axonal guidance. For example, modulation of PKC and FAK expression or activity, both in vivo and ex vivo, influences neuronal migration, neurite outgrowth and axonal branching [105] [106] [107] [108] . Active src is detected in rat axons during neuronal regeneration, and disrupted srC-1 expression in C. elegans induces growth-cone migration and directionality defects 109, 110 . Furthermore, expression of Fyn is increased in rat neurons following neural trauma 111 , and Fyn overexpression in Xenopus laevis primary sensory neurons results in aberrant axonal targeting 112 . The rac orthologues expressed in D. melanogaster (rac1, rac2 and Mtl) and C. elegans (CEd-10, MIG-2 and rAC-2), and their downstream PAK effectors, are essential for axon growth, pathfinding and branching [113] [114] [115] [116] . Indeed, membrane targeting of PAK in rat cells in vitro is sufficient to promote neurite outgrowth 117 . A recent study has demonstrated the complexity of rho GTPase signalling in vivo and highlighted the requirement for multiple rac-and rho-dependent signalling pathways, both convergent and divergent, for the precise regulation of axonal growth and targeting in D. melanogaster 118 . Given the complexity of this system, it is likely that the discrete spatial and temporal regulation of these signalling pathways will be mediated by cell-surface receptors acting as environmental sensors. At this stage, however, the signalling connections from integrins and syndecans to neuronal development are mainly attributable to educated speculation.
The complexity of integrin-syndecan synergy in vivo.
The analysis of the synergistic relationship between integrins and syndecans in vitro allows investigators to isolate the distinct signals that are elicited by engagement of individual receptors. However, it is clear that regulation of cellular functions by these receptors in vivo is considerably more complicated and involves integration with, and signals arising from, many other receptor systems. This is highlighted by the diverse range of soluble and membrane-associated ligands for heparan sulphate glycosaminoglycan chains. Consequently, it is unlikely that integrin-syndecan synergy is mediated by a single universal mechanism. It is more likely that it is mediated through several different mechanisms (FIG. 6) that can each regulate a subset of functions depending on cellular context and the dynamic regulation, both spatial and temporal, of interactions with ECM, growth factors, chemokines, directional cues and receptor Tyr kinases/ phosphatases. Therefore, we propose four mechanisms by which integrins and syndecans could functionally synergize and interact with various different ligands and receptors to elicit specific intracellular signals in vivo (FIG. 6) , and suggest that the transition between these different modes of interaction and signalling could be regulated by dynamic changes in the extracellular environment. However, it is apparent that an even greater level of complexity exists in the regulation of such synergistic signalling. Examples of mechanisms that could further modulate integrin-syndecan synergy include: the localization (through direct association) of growth factors to the ECM; the integrin-mediated activation of specific growth factors; integrin-affinity modulation; endocytosis of receptors; and the regulation of syndecan signalling through extracellular domain shedding.
Perspectives
It is evident from the review of the literature presented in this article that there is a substantial overlap in the signalling pathways that are influenced by integrin and syndecan ligation. A major challenge is now to identify the points of convergence between these signalling networks. A substantial body of literature also supports a functional synergy between integrins and syndecans that affects many adhesion-dependent processes observed in vivo. Perhaps the most surprising discovery to arise from these studies is that disruption of syndecan expression is a non-lethal event, suggesting that the cooperation of receptors is most apparent when cells are challenged to migrate by a change in environment, rather than during developmental morphogenesis. whether the difference between developmental and pathological cell migration is due to varied compensation between adhesion receptors is unclear, but we speculate that some higher functions of eukaryotes, such as repair, inflammation and angiogenesis, required the evolution of a second tier of adhesion and signalling molecules that include the syndecans and a subset of integrins (such as the β 2 and α v subfamilies) 119 . Important areas of future investigation are likely to include elucidation of the signalling networks that mediate synergistic signalling, with emphasis on the spatial and temporal regulation of these events. Also, a more detailed analysis of the contributions of integrins and syndecans to repair processes in vivo, in particular in wound healing, is needed. Notably, most in vitro studies have focused on syndecan-4 signalling, whereas most in vivo studies have dealt with syndecan-1, which means that large sections of syndecan biology remain unresolved. Given the crosstalk and feedback that exists between signalling pathways, there is unlikely to be a single solution to the challenge of enhancing repair processes in vivo, but the therapeutic implications of understanding receptor synergy make such investigations of utmost importance.
